Reference health
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
181/181 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 181 checked references that resolve
resolves10.1097/NEN.0b013e3181919a48
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
resolves10.1111/jnc.15007
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain
resolves10.3233/JAD-2006-9S312
Alzheimer's disease-related alterations in synaptic density: Neocortex and hippocampus
resolves10.1038/s41582-018-0116-6
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
resolves10.1038/s41583-019-0132-6
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
resolves10.1016/S1471-4914(01)02173-6
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
resolves10.1016/j.bbadis.2013.10.015
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
resolves10.1212/01.WNL.0000156156.13641.BA
Evidence of increased oxidative damage in subjects with mild cognitive impairment
resolves10.1016/j.freeradbiomed.2014.06.006
The 2013 SFRBM discovery award: Selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment
resolves10.1016/j.freeradbiomed.2018.12.029
The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (“chemobrain”) involving TNF-α
resolves10.1016/j.freeradbiomed.2005.08.043
The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy
resolves10.1146/annurev-biochem-060815-014431
Multiple Functions and Regulation of Mammalian Peroxiredoxins
resolves10.1089/ars.2017.7115
GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues
resolves10.3390/antiox7090122
The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases
resolves10.1016/j.brainresbull.2016.06.005
Oxidative stress, protein modification and Alzheimer disease
resolves10.1016/j.freeradbiomed.2019.08.008
Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease
resolves10.1089/ars.2012.4523
The Electrophile Responsive Proteome: Integrating Proteomics and Lipidomics with Cellular Function
resolves10.1046/j.1471-4159.2001.00451.x
The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42
resolves10.1016/j.redox.2013.01.002
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
resolves10.1046/j.1471-4159.1997.69031161.x
The Lipid Peroxidation Product, 4‐Hydroxy‐2‐<i>trans</i>‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins
resolves10.1073/pnas.1804932115
Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine
resolves10.1016/j.nbd.2014.08.025
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
resolves10.1016/j.nbd.2020.104795
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
resolves10.3233/JAD-2011-101425
Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder
resolves10.1016/j.freeradbiomed.2013.08.001
Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease
resolves10.1523/JNEUROSCI.2385-16.2017
Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
resolves10.1093/hmg/ddx299
Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model
resolves10.3233/JAD-170051
Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer’s Disease
resolves10.1016/S0891-5849(02)00914-0
Proteomic identification of oxidatively modified proteins in alzheimer’s disease brain. part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1
resolves10.1089/ars.2011.4109
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
resolves10.1089/ars.2006.8.2021
Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics
resolves10.1089/ars.2011.4406
4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies
resolves10.1016/j.freeradbiomed.2012.09.027
Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain
resolves10.1016/j.arr.2013.12.005
Redox proteomics and the dynamic molecular landscape of the aging brain
resolves10.1042/BJ20140772
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
resolves10.1089/ars.2016.6759
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
resolves10.1016/j.bbadis.2011.10.011
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics
resolves10.1002/prca.200800161
Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis
resolves10.1016/j.brainres.2009.04.009
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD
resolves10.1016/j.nbd.2007.12.007
Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease
resolves10.1016/j.nbd.2005.10.004
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach
resolves10.1111/j.1582-4934.2007.00065.x
Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study
resolves10.1089/ars.2009.2810
Redox Proteomic Analysis of Carbonylated Brain Proteins in Mild Cognitive Impairment and Early Alzheimer's Disease
resolves10.3233/JAD-2010-101083
Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI
resolves10.1111/j.1750-3639.2009.00266.x
Mitochondrial ATP‐Synthase in the Entorhinal Cortex Is a Target of Oxidative Stress at Stages I/II of Alzheimer's Disease Pathology
resolves10.1179/1351000213Y.0000000073
Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species
resolves10.1016/j.jprot.2015.04.005
Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage
resolves10.1002/jnr.20876
Protective effect of D609 against amyloid-beta1–42-induced oxidative modification of neuronal proteins: Redox proteomics study
resolves10.1016/j.neurobiolaging.2005.07.001
Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1–42): Implications for Alzheimer's disease
resolves10.1371/journal.pone.0002915
Evidence for the Mitochondrial Lactate Oxidation Complex in Rat Neurons: Demonstration of an Essential Component of Brain Lactate Shuttles
resolves10.1097/00004647-199611000-00001
Selective Distribution of Lactate Dehydrogenase Isoenzymes in Neurons and Astrocytes of Human Brain
resolves10.1523/JNEUROSCI.0415-11.2011
<i>In Vivo</i>Evidence for Lactate as a Neuronal Energy Source
resolves10.1083/jcb.201803152
Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism
resolves10.1016/j.jprot.2011.06.015
Proteomic identification of specifically carbonylated brain proteins in APPNLh/APPNLh×PS-1P264L/PS-1P264L human double mutant knock-in mice model of Alzheimer disease as a function of age
resolves10.1073/pnas.090106797
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
resolves10.1016/j.neurobiolaging.2006.12.008
Hippocampal hypometabolism predicts cognitive decline from normal aging
resolves10.1007/s00259-008-1039-z
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease
resolves10.3389/fendo.2018.00196
Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?
resolves10.1016/j.arr.2016.04.006
Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases
resolves10.1016/S0092-8674(02)01250-3
Molecular Chaperones Hsp90 and Hsp70 Deliver Preproteins to the Mitochondrial Import Receptor Tom70
resolves10.1158/0008-5472.CAN-04-3835
p53 Translocation to Mitochondria Precedes Its Nuclear Translocation and Targets Mitochondrial Oxidative Defense Protein-Manganese Superoxide Dismutase
resolves10.1007/s10863-016-9669-5
p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases
resolves10.1016/j.freeradbiomed.2008.03.015
Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease
resolves10.1111/j.1582-4934.2008.00163.x
Elevated levels of pro‐apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE,in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease
resolves10.1371/journal.pone.0049846
Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53
resolves10.1038/sj.onc.1204101
Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis
resolves10.1158/0008-5472.CAN-11-1233
Manganese Superoxide Dismutase Is a
<i>p53</i>
-Regulated Gene That Switches Cancers between Early and Advanced Stages
resolves10.1002/jnr.23627
Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53
resolves10.3233/JAD-151105
Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype
resolves10.15698/cst2017.10.104
VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
resolves10.1042/BJ20112079
Structure-based analysis of VDAC1: N-terminus location, translocation, channel gating and association with anti-apoptotic proteins
resolves10.1016/S0006-291X(03)00871-4
Identification of the protein–protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins
resolves10.1242/jcs.040188
The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins
resolves10.1074/jbc.M109.082990
Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity
resolves10.1074/jbc.M112.345918
Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein
resolves10.1016/j.bbamcr.2016.04.002
VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis
resolves10.1093/hmg/dds360
Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease
resolves10.1042/bj20031465
In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death
resolves10.1074/jbc.M708216200
Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1
resolves10.1074/jbc.M115.691493
The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy
resolves10.1007/s11011-011-9253-y
Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease
resolves10.1016/S0197-4580(03)00033-2
Cytochrome c oxidase is decreased in Alzheimer’s disease platelets
resolves10.1016/S0197-4580(01)00314-1
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease
resolves10.3233/JAD-142052
Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment
resolves10.1016/j.neuroscience.2013.10.026
Differential S-nitrosylation of proteins in Alzheimer’s disease
resolves10.1074/mcp.M113.036079
Global Analysis of S-nitrosylation Sites in the Wild Type (APP) Transgenic Mouse Brain-Clues for Synaptic Pathology
resolves10.1111/jnc.14870
Quantitative proteomics of synaptosome <i>S</i>‐nitrosylation in Alzheimer’s disease
resolves10.1016/j.nbd.2015.03.017
Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
resolves10.1016/S0891-5849(02)00794-3
Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
resolves10.1152/physrev.1997.77.3.731
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
resolves10.1146/annurev.genet.39.110304.095751
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
resolves10.3390/ijms161125939
Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism
resolves10.1016/j.exger.2017.07.004
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease
resolves10.3233/JAD-180202
Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease
resolves10.1111/j.1471-4159.2009.06333.x
Astrocytes are poised for lactate trafficking and release from activated brain and for supply of glucose to neurons
resolves10.1016/j.nbd.2020.104742
APOE alters glucose flux through central carbon pathways in astrocytes
resolves10.3390/biom6020016
Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain
resolves10.4103/1673-5374.274328
Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders
resolves10.1002/ana.410400512
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
resolves10.1038/sj.jcbfm.9600343
Energy Metabolism in Astrocytes: High Rate of Oxidative Metabolism and Spatiotemporal Dependence on Glycolysis/Glycogenolysis
resolves10.1073/pnas.88.23.10540
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
resolves10.1046/j.1471-4159.1995.65052146.x
Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation
resolves10.1016/j.jalz.2017.01.020
Metabolic network failures in Alzheimer's disease: A biochemical road map
resolves10.1016/j.jpba.2014.10.010
Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
resolves10.1093/brain/awp062
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
resolves10.1056/NEJMoa1202753
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
resolves10.1016/S1474-4422(12)70228-4
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
resolves10.1016/S1474-4422(13)70044-9
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
resolves10.1016/S1474-4422(18)30028-0
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
resolves10.3233/JAD-170543
Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease
resolves10.1006/exnr.1995.1080
Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress
resolves10.1136/jmg.38.6.353
The −48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain
resolves10.1016/S0197-4580(02)00225-7
Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model
resolves10.1007/s10072-019-03863-x
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease
resolves10.1007/s40263-019-00658-8
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
resolves10.1016/j.neurobiolaging.2006.09.012
Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease
resolves10.1046/j.1471-4159.2003.01580.x
The antioxidants α‐lipoic acid and <i>N</i>‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice
resolves10.1016/S0167-4943(01)00104-2
Alpha-lipoic acid as a new treatment option for Azheimer type dementia
resolves10.1007/s12031-007-9033-7
Coenzyme Q10 Attenuates β-Amyloid Pathology in the Aged Transgenic Mice with Alzheimer Presenilin 1 Mutation
resolves10.1523/JNEUROSCI.0552-11.2011
The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
resolves10.1111/j.1467-789X.2010.00825.x
Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies
resolves10.1016/j.dadm.2017.05.007
Body mass index in midlife and dementia: Systematic review and meta‐regression analysis of 589,649 men and women followed in longitudinal studies
resolves10.1159/000231980
Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later
resolves10.3233/JAD-140954
Midlife Vascular Risk Factors and the Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis
resolves10.1212/WNL.0b013e318227b227
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
resolves10.1161/HYPERTENSIONAHA.110.163055
Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly
resolves10.1001/jamaneurol.2017.1658
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort
resolves10.1002/ana.21557
The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late life
resolves10.1111/jdi.12087
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
resolves10.1093/epirev/mxs012
Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship
resolves10.1016/j.mayocp.2016.04.024
Physical Activity and Alzheimer Disease: A Protective Association
resolves10.1006/geno.1994.1525
Marked Changes in Mitochondrial DNA Deletion Levels in Alzheimer Brains
resolves10.1073/pnas.0403649101
Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication
resolves10.1016/j.neurobiolaging.2011.08.009
Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease
resolves10.1016/j.jalz.2014.11.009
MIND diet associated with reduced incidence of Alzheimer's disease
resolves10.3389/fnut.2016.00022
Adherence to a Mediterranean-Style Diet and Effects on Cognition in Adults: A Qualitative Evaluation and Systematic Review of Longitudinal and Prospective Trials
resolves10.1016/j.jalz.2019.07.013
Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults
resolves10.1016/j.jalz.2017.09.006
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial
resolves10.1001/jamaneurol.2017.4365
Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention
resolves10.1186/s13195-019-0506-z
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
resolves10.1111/bpa.12403
Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against <scp>A</scp>lzheimer's Disease
resolves10.1016/j.bbadis.2016.04.017
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
resolves10.1016/j.bbadis.2015.05.001
Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers
resolves10.1016/j.mito.2018.04.004
Etiology of type 2 diabetes and Alzheimer's disease: Exploring the mitochondria
The 6 references without a DOI — listed, not checked
no DOI — not checkedMalate Dehydrogenases—Structure and Function
no DOI — not checkedDifferential neuronal expression of manganese superoxide dismutase in Alzheimer’s disease
no DOI — not checkedVDAC1 as a player in mitochondria-mediated apoptosis and target for modulating apoptosis
no DOI — not checkedNakao, K., Minato, N., and Uemoto, S. (2015). Diverting glycolysis to combat oxidative stress. Innovative Medicine: Basic Research and Development, Springer.
no DOI — not checkedPhysical activity and Alzheimer’s disease: A Systematic Review
no DOI — not checkedPhysical activity, brain volume, and dementia risk: The Framingham Study
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3390/antiox9090818"><img src="https://citestamp.com/citestamped/10.3390/antiox9090818/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3390/antiox9090818)